Literature DB >> 27588098

Separation of cordycepin from Cordyceps militaris fermentation supernatant using preparative HPLC and evaluation of its antibacterial activity as an NAD+-dependent DNA ligase inhibitor.

Xiaofeng Zhou1, Guoqiang Cai2, Yi He1, Guotong Tong1.   

Abstract

Cordycepin exhibits various bio-activities, including anticancer, antibacterial, antiviral and immune regulation activities, and is a significant focus of research. However, the preparation of high-purity cordycepin remains challenging. Also, the molecular target with which cordycepin interacts to cause an antibacterial effect remains unknown. In the present study, cordycepin was prepared by preparative high-performance liquid chromatography (prep-HPLC) and the purity obtained was 99.6%, indicating that this technique may be useful for the large-scale isolation of cordycepin in the future. The results of computational molecular docking analysis indicated that the interaction energy between cordycepin and NAD+-dependent DNA ligase (LigA) was lower than that between cordycepin and other common antibacterial targets. The highly pure cordycepin obtained by prep-HPLC demonstrated inhibitory activity against LigA from various bacteria in vitro. In conclusion, cordycepin may be useful as a broad-spectrum antibiotic targeting LigA in various bacteria.

Entities:  

Keywords:  NAD+-dependent DNA ligase inhibitor; bio-activity; broad-spectrum antibiotic; cordycepin; high-performance liquid chromatography

Year:  2016        PMID: 27588098      PMCID: PMC4998010          DOI: 10.3892/etm.2016.3536

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  23 in total

1.  A high-throughput resonance energy transfer assay for Staphylococcus aureus DNA ligase.

Authors:  Ericka L Benson; Paul K Tomich; Mark L Wolfe; Gil H Choi; Jeanne C Hagadorn; Veronica T Mutchler; Robert L Garlick
Journal:  Anal Biochem       Date:  2004-01-15       Impact factor: 3.365

Review 2.  A review of protein-small molecule docking methods.

Authors:  R D Taylor; P J Jewsbury; J W Essex
Journal:  J Comput Aided Mol Des       Date:  2002-03       Impact factor: 3.686

3.  Novel bacterial NAD+-dependent DNA ligase inhibitors with broad-spectrum activity and antibacterial efficacy in vivo.

Authors:  Scott D Mills; Ann E Eakin; Ed T Buurman; Joseph V Newman; Ning Gao; Hoan Huynh; Kenneth D Johnson; Sushmita Lahiri; Adam B Shapiro; Grant K Walkup; Wei Yang; Suzanne S Stokes
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

4.  Optimization of fermentation conditions and purification of cordycepin from Cordyceps militaris.

Authors:  Tang Jiapeng; Liu Yiting; Zhu Li
Journal:  Prep Biochem Biotechnol       Date:  2014       Impact factor: 2.162

5.  Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells.

Authors:  E N Kodama; R P McCaffrey; K Yusa; H Mitsuya
Journal:  Biochem Pharmacol       Date:  2000-02-01       Impact factor: 5.858

6.  Inhibition of the replication of a hepatitis C virus-like RNA template by interferon and 3'-deoxycytidine.

Authors:  Robert W King; Marianne Zecher; Matthew W Jefferies
Journal:  Antivir Chem Chemother       Date:  2002-11

7.  Cordycepin is an immunoregulatory active ingredient of Cordyceps sinensis.

Authors:  Xiaoxia Zhou; Liping Luo; Waike Dressel; Gulibahaer Shadier; Doreen Krumbiegel; Peter Schmidtke; Fred Zepp; Claudius U Meyer
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

8.  The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines.

Authors:  Hellinida Thomadaki; Chris Milto Tsiapalis; Andreas Scorilas
Journal:  Cancer Chemother Pharmacol       Date:  2007-06-13       Impact factor: 3.333

9.  Column chromatographic extraction and preparation of cordycepin from Cordyceps militaris waster medium.

Authors:  He Ni; Xiao-Hong Zhou; Hai-Hang Li; Wen-Fang Huang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-06-13       Impact factor: 3.205

10.  The selective interruption of nucleolar RNA synthesis in HeLa cells by cordycepin.

Authors:  M Siev; R Weinberg; S Penman
Journal:  J Cell Biol       Date:  1969-05       Impact factor: 10.539

View more
  7 in total

1.  A study of the aphrodisiac properties of Cordyceps militaris in streptozotocin-induced diabetic male rats.

Authors:  Toan Van Nguyen; Pramote Chumnanpuen; Kongphop Parunyakul; Krittika Srisuksai; Wirasak Fungfuang
Journal:  Vet World       Date:  2021-02-27

2.  Evaluation of Anti-Biofilm Capability of Cordycepin Against Candida albicans.

Authors:  Yu Wang; Zejun Pei; Zaixiang Lou; Hongxin Wang
Journal:  Infect Drug Resist       Date:  2021-02-05       Impact factor: 4.003

3.  Xanthine Oxidase Inhibitory Potential, Antioxidant and Antibacterial Activities of Cordyceps militaris (L.) Link Fruiting Body.

Authors:  Tran Ngoc Quy; Tran Dang Xuan
Journal:  Medicines (Basel)       Date:  2019-01-29

4.  Cordycepin Isolated from Cordyceps militaris: Its Newly Discovered Herbicidal Property and Potential Plant-Based Novel Alternative to Glyphosate.

Authors:  Tran Ngoc Quy; Tran Dang Xuan; Yusuf Andriana; Hoang-Dung Tran; Tran Dang Khanh; Rolf Teschke
Journal:  Molecules       Date:  2019-08-09       Impact factor: 4.411

5.  Transcriptomic Responses of Cordyceps militaris to Salt Treatment During Cordycepins Production.

Authors:  Gongbo Lv; Yue Zhu; Xiaojie Cheng; Yan Cao; Bin Zeng; Xinping Liu; Bin He
Journal:  Front Nutr       Date:  2021-12-23

6.  Dynamic Genome-Wide Transcription Profiling and Direct Target Genes of CmWC-1 Reveal Hierarchical Light Signal Transduction in Cordyceps militaris.

Authors:  Jiaojiao Zhang; Fen Wang; Mengqian Liu; Mingjia Fu; Caihong Dong
Journal:  J Fungi (Basel)       Date:  2022-06-11

7.  Development of High Cordycepin-Producing Cordyceps militaris Strains.

Authors:  Naru Kang; Hyun-Hee Lee; Inmyoung Park; Young-Su Seo
Journal:  Mycobiology       Date:  2017-03-31       Impact factor: 1.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.